Trial Profile
Perampanel for the prevention of post-stroke epilepsy- efficacy and safety: a pilot phase II randomised controlled trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Apr 2022
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Epilepsy; Stroke complications
- Focus Therapeutic Use
- Acronyms PEPSTEP
- 18 May 2021 Planned End Date changed from 30 Dec 2022 to 31 Oct 2023.
- 17 Dec 2018 New trial record